Absci (ABSI)

• Market cap: $381M
• 1 day: -5.56%
• 5 days: 1.19%
• 1 month: -9.89%
• 3 months: -5.9%
• 6 months: -20.56%
• Year to date: -5.9%
• 1 year: -35.44%
• 5 years: -88.19%
• 10 years: -88.19%
• Sector: Healthcare
• Industry: Biotechnology

About: Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Employees: 157

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

65% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 34

7% more capital invested

Capital invested by funds: $215M [Q1] → $230M (+$15.4M) [Q2]

3.02% more ownership

Funds ownership: 67.16% [Q1] → 70.18% (+3.02%) [Q2]

6% less funds holding

Funds holding: 139 [Q1] → 130 (-9) [Q2]

12% less call options, than puts

Call options by funds: $1.77M | Put options by funds: $2M

35% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 23

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $5.89
• Avg. target: $6.95
• High target: $8

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Morgan Stanley Vikram Purohit	$5.89	Overweight Maintained	18 Aug 2025
Needham Gil Blum	$8	Buy Maintained	13 Aug 2025